Unknown PHASE4 INTERVENTIONAL 2-arm NCT02584738

Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

Efficacy of Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation. A Randomized Controlled Trial

Sponsor: Hospital General Naval de Alta Especialidad - Escuela Medico Naval

Conditions Asthma

Interventions Ipratropium bromide Methylprednisolone or Prednisolone Nebulized Magnesium Sulfate Nebulized Salbutamol Nebulized isotonic saline

Updated 7 times since 2017 Last updated: Nov 30, 2015 Started: Sep 30, 2015 Primary completion: Jan 31, 2016 Completion: Jan 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Asthma, this trial is ongoing. The trial is conducted by Hospital General Naval de Alta Especialidad - Escuela Medico Naval and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital General Naval de Alta Especialidad - Escuela Medico Naval

Data source: Hospital General Naval de Alta Especialidad - Escuela Medico Naval

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico